Charted
Saturday, Nov. 21, 2026The business of health, by the numbers
Live trackersDeal tracker $50.9B raisedFDA clearances 293 510(k)s in OctoberForm D raises $1.5B in 30 daysNew trials 266 Phase 2/3 in 30 days
№01·Health Tech

Danaher enlists Microsoft to put AI agents in its lab instruments, with more due 2027

The shared platform runs on Azure and Microsoft Foundry. The first product, an assistant for Molecular Devices imaging systems, is due this year. Financial terms were not disclosed.

Charted StaffNov. 21 · 3 min read
The Life Sciences Complex at Syracuse University, which houses the biology, chemistry and biochemistry departments and research labs. File photo.Kiran891 / Wikimedia Commons (CC BY-SA 4.0)

The Latest

Nov. 17 – Nov. 203 stories

Earlier

Nov. 173 stories
Deal tracker
$50.9Braised

Disclosed funding across 527 venture rounds, IPOs, private placements and Form D raises tracked since Jan. 6. The tracker also lists 103 acquisitions; those priced in dollars total $239B.

FDA clearances
293510(k)s in October

FDA cleared 293 devices through the 510(k) pathway in October 2026, 8% fewer than the month before. The busiest review panels were orthopedic (42), general, plastic surgery (40), cardiovascular (34).

Form D raises
$1.5Bin 30 days

117 health-care companies reported selling $1.5B in private offerings on new Form D filings in the past 30 days. By industry: other health care 54, biotechnology 49, pharmaceuticals 9, hospitals and physicians 4, health insurance 1.

New trials
266Phase 2/3 in 30 days

Companies registered 266 new Phase 2 or Phase 3 interventional trials on ClinicalTrials.gov in the past 30 days, 115 of them Phase 3.

DateCompanyTypeAmountLed by / buyerSector
Nov. 19Laza MedicalForm D$70.5MBiotech
Nov. 19InflammatixForm D$47.4MBiotech
Nov. 18Rising Tide Dental HoldingsForm D$61.7MOther Health Care
Nov. 18Ansa BiotechnologiesSeries C$71.5MBlue Water Life Science AdvisorsBiotech
Nov. 17Marrow TherapeuticsSeries B$173MOrbiMed, Scion Life Sciences, venBioBiotech
Nov. 17ODAIASeries C$15MMonograph CapitalHealth AI
Nov. 17Isomorphic LabsSeries C$5BGreenoaks, Sequoia CapitalBiotech
Nov. 17ScienceSeries D$400MMedtech
Nov. 17Onward TherapeuticsSeries B$28MBiotech
Nov. 17Commit BiologicsSeed$60MAckermans & van HaarenBiotech
Newsletter

Charted Daily

The day's deals, FDA decisions and policy moves, by the numbers. Free. Sign up now to get the first edition.

No spam. Unsubscribe any time.